Sonoma Pharmaceuticals secures new supply agreement

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) has entered into a significant agreement with WellSpring Pharmaceutical Corporation. Announced on Thursday, the Master Supply Agreement, effective January 29, 2025, will enable Sonoma to distribute its Microcyn® technology-based products to major retailers across the United States.

The agreement stipulates an initial two-year term, with the potential for extension through three successive one-year renewals. This partnership marks a strategic move for Sonoma Pharmaceuticals in expanding its product reach in the U.S. retail market.

You May Also Be Interested In

• Ashland said to explore sale amid takeover interest - Bloomberg
• IM Cannabis closes $250,000 convertible note deal with institutional investor
• First Phosphate ADRs uplisted to Nasdaq Global Market as PHOS